NM_001643.2:c.288G>A
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001643.2(APOA2):c.288G>A(p.Gln96Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000527 in 1,614,136 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001643.2 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -17 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00284 AC: 432AN: 152204Hom.: 1 Cov.: 31
GnomAD3 exomes AF: 0.000648 AC: 163AN: 251442Hom.: 0 AF XY: 0.000603 AC XY: 82AN XY: 135896
GnomAD4 exome AF: 0.000287 AC: 419AN: 1461814Hom.: 3 Cov.: 30 AF XY: 0.000250 AC XY: 182AN XY: 727210
GnomAD4 genome AF: 0.00284 AC: 432AN: 152322Hom.: 1 Cov.: 31 AF XY: 0.00277 AC XY: 206AN XY: 74484
ClinVar
Submissions by phenotype
not provided Benign:2
- -
Variant summary: The APOA2 c.288G>A (p.Gln96Gln) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. One in silico tool predicts a benign outcome for this variant. 4/5 splice prediction tools predict no significant impact on normal splicing. ESE finder predicts that this variant may affect ESE sites. However, these predictions have yet to be confirmed by functional studies. This variant was found in 88/121348 control chromosomes at a frequency of 0.0007252, which is approximately 36 times the estimated maximal expected allele frequency of a pathogenic APOA2 variant (0.00002), suggesting this variant is likely a benign polymorphism. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as benign. -
not specified Benign:1
- -
APOA2-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at